ClinicalTrials.Veeva

Menu

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Venous Thromboembolism

Treatments

Behavioral: electronic alerts

Study type

Interventional

Funder types

Other

Identifiers

NCT01598805
FZMI-KEK-ZH-Nr. 2010-0458

Details and patient eligibility

About

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

Full description

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

Enrollment

10,000 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
  • staying at least 24 h in a ward

Exclusion criteria

  • outpatients,
  • ward without CPOE,
  • patients transferred from an intervention to a control ward and vice versa

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

10,000 participants in 1 patient group

roll out of eAlerts
Experimental group
Description:
Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Treatment:
Behavioral: electronic alerts

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems